FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964410054> ?p ?o ?g. }

• W1964410054 endingPage "355" @default.
• W1964410054 startingPage "347" @default.
• W1964410054 abstract "In the present study, we used [3H]norethisterone to explore the bioconversion of this compound to A-ring reduced metabolites in African Green Monkey Kidney CV-1 cells and breast cancer T-47D cells. Additionally, we analyzed the capability of each norethisterone tetrahydro-reduced compound to bind the human oestrogen receptors alpha and beta and transactivate an oestrogen-sensitive reporter gene. The results showed that norethisterone is mainly metabolized to 3 alpha,5 alpha-norethisterone (>85% of total [3H]norethisterone added) by CV-1 and T-47D cells, and that both A-ring tetrahydro-reduced metabolites exhibit different capabilities to displace [3H]17beta-oestradiol from the oestrogen receptor alpha and beta, being 3 alpha,5 alpha-norethisterone the weakest competitor. We also found that 3 alpha,5 alpha-norethisterone and 3beta,5 alpha-norethisterone activate both oestrogen receptors at nanomolar concentrations and that the transactivation induced by the oestrogen receptor alpha was generally higher (1.7- to 4.0-fold) than that provoked by the beta receptor isoform. In oestrogen receptor alpha-transfected CV-1 and T-47 D cells, the oestrogenic-like potency of the 3beta,5 alpha-tetrahydro-reduced form was similar to that exhibited by 17beta-oestradiol and 2.5- to 4.0-fold higher than that shown by the 3 alpha,5 alpha-reduced compound; conversely, in the oestrogen receptor beta system the potency of the natural ligand was higher than that presented by the 3beta,5 alpha-tetrahydro-reduced metabolite. In CV-1 cells expressing the oestrogen receptor beta, the transactivation potency of 3beta,5 alpha-norethisterone was approximately 2-fold higher than that exhibited by its 3 alpha,5 alpha-tetrahydro-reduced isomer, whereas in T-47D cells the potency of the 3 alpha,5 alpha-tetrahydro-reduced compound was slightly higher than that shown by the 3beta,5 alpha A-ring reduced norethisterone metabolite. These results demonstrate that CV-1 and T-47D cells possess the enzymatic machinery to bioconvert norethisterone into the 5 alpha-reduced, 3 alpha-hydroxylated form and that neither 3 alpha,5 alpha- or 3beta,5 alpha-norethisterone exhibit preference or selectivity towards a particular oestrogen receptor isoform to induce a particular oestrogenic effect in these cell lines." @default.
• W1964410054 created "2016-06-24" @default.
• W1964410054 creator A5004553549 @default.
• W1964410054 creator A5033990421 @default.
• W1964410054 creator A5041567181 @default.
• W1964410054 creator A5062480238 @default.
• W1964410054 creator A5080659937 @default.
• W1964410054 creator A5091544293 @default.
• W1964410054 date "2002-10-01" @default.
• W1964410054 modified "2023-10-16" @default.
• W1964410054 title "Norethisterone is bioconverted to oestrogenic compounds that activate both the oestrogen receptor α and oestrogen receptor β in vitro" @default.
• W1964410054 cites W1497395693 @default.
• W1964410054 cites W1541234884 @default.
• W1964410054 cites W1571876143 @default.
• W1964410054 cites W1622904595 @default.
• W1964410054 cites W1963566385 @default.
• W1964410054 cites W1970703128 @default.
• W1964410054 cites W1971960644 @default.
• W1964410054 cites W1972323894 @default.
• W1964410054 cites W1981686096 @default.
• W1964410054 cites W1985614757 @default.
• W1964410054 cites W1992610872 @default.
• W1964410054 cites W1999497931 @default.
• W1964410054 cites W2001297734 @default.
• W1964410054 cites W2003027184 @default.
• W1964410054 cites W2007199133 @default.
• W1964410054 cites W2020834476 @default.
• W1964410054 cites W2021882870 @default.
• W1964410054 cites W2028706115 @default.
• W1964410054 cites W2035090518 @default.
• W1964410054 cites W2038599327 @default.
• W1964410054 cites W2043190004 @default.
• W1964410054 cites W2043848949 @default.
• W1964410054 cites W2045197131 @default.
• W1964410054 cites W2049250767 @default.
• W1964410054 cites W2053471894 @default.
• W1964410054 cites W2059923379 @default.
• W1964410054 cites W2063981851 @default.
• W1964410054 cites W2064004433 @default.
• W1964410054 cites W2066441904 @default.
• W1964410054 cites W2068331537 @default.
• W1964410054 cites W206917024 @default.
• W1964410054 cites W2073944950 @default.
• W1964410054 cites W2074777274 @default.
• W1964410054 cites W2077517423 @default.
• W1964410054 cites W2081484436 @default.
• W1964410054 cites W2089260361 @default.
• W1964410054 cites W2094008928 @default.
• W1964410054 cites W2094884232 @default.
• W1964410054 cites W2100049410 @default.
• W1964410054 cites W2141569065 @default.
• W1964410054 cites W2148576257 @default.
• W1964410054 cites W2151062591 @default.
• W1964410054 cites W2171148899 @default.
• W1964410054 cites W2319997735 @default.
• W1964410054 cites W2403801778 @default.
• W1964410054 doi "https://doi.org/10.1016/s0014-2999(02)02337-3" @default.
• W1964410054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12359276" @default.
• W1964410054 hasPublicationYear "2002" @default.
• W1964410054 type Work @default.
• W1964410054 sameAs 1964410054 @default.
• W1964410054 citedByCount "11" @default.
• W1964410054 countsByYear W19644100542015 @default.
• W1964410054 countsByYear W19644100542016 @default.
• W1964410054 countsByYear W19644100542017 @default.
• W1964410054 countsByYear W19644100542018 @default.
• W1964410054 countsByYear W19644100542021 @default.
• W1964410054 countsByYear W19644100542022 @default.
• W1964410054 crossrefType "journal-article" @default.
• W1964410054 hasAuthorship W1964410054A5004553549 @default.
• W1964410054 hasAuthorship W1964410054A5033990421 @default.
• W1964410054 hasAuthorship W1964410054A5041567181 @default.
• W1964410054 hasAuthorship W1964410054A5062480238 @default.
• W1964410054 hasAuthorship W1964410054A5080659937 @default.
• W1964410054 hasAuthorship W1964410054A5091544293 @default.
• W1964410054 hasConcept C104317684 @default.
• W1964410054 hasConcept C121608353 @default.
• W1964410054 hasConcept C126322002 @default.
• W1964410054 hasConcept C1292079 @default.
• W1964410054 hasConcept C134018914 @default.
• W1964410054 hasConcept C150194340 @default.
• W1964410054 hasConcept C159110408 @default.
• W1964410054 hasConcept C170493617 @default.
• W1964410054 hasConcept C172313692 @default.
• W1964410054 hasConcept C185592680 @default.
• W1964410054 hasConcept C2775944032 @default.
• W1964410054 hasConcept C2777477808 @default.
• W1964410054 hasConcept C2781039349 @default.
• W1964410054 hasConcept C2908647359 @default.
• W1964410054 hasConcept C2986817661 @default.
• W1964410054 hasConcept C49453240 @default.
• W1964410054 hasConcept C530470458 @default.
• W1964410054 hasConcept C55493867 @default.
• W1964410054 hasConcept C64943373 @default.
• W1964410054 hasConcept C71924100 @default.
• W1964410054 hasConcept C84606932 @default.
• W1964410054 hasConcept C86803240 @default.
• W1964410054 hasConcept C99454951 @default.

• next